Table 3 Compared patient data in the “eradication” and “persistence” groups. Results are expressed in numbers or mean ± standard deviation
Patient data | Eradication (N = 10) | Persistence (N = 7) | p value |
|---|---|---|---|
Male | 8 | 5 | 1 |
Age at PC (years) | 19.1 ± 8.6 | 20.2 ± 8.0 | 0.74 |
BMI (Z-score) at PC | −1.04 ± 0.8 | −0.62 ± 0.6 | 0.42 |
Antibiotics in the 3 months before PC | 9 | 3 | 0.1 |
Lung function (% predicted) | |||
FVC at PC | 92.8 ± 15.6 | 65.3 ± 20.1 | 0.11 |
FEV1 at PC | 85.4 ± 27.4 | 65.7 ± 23.0 | 0.12 |
FEV1 2 years after PCa | 77.7 ± 26.1 | 57.2 ± 18.4 | 0.08 |
Distribution ofBurkholderiastrains at PC | |||
BCC | 8 | 6 | |
B. multivorans | 3 | 3 | 0.64 |
B. cenocepacia | 2 | 2 | 1 |
B. contaminans | 1 | 0 | 1 |
B. vietnamiensis | 1 | 0 | 1 |
B. ambifaria | 0 | 1 | 0.41 |
Unidentified BCC | 1 | 0 | 1 |
B. gladioli | 2 | 1 | 1 |
Antibiotic treatment | |||
No treatment | 4 | 2 | 1 |
Eradication treatment | 6 | 5 | 1 |
Time to treat from the PC (days) | 34 ± 20.5 | 48 ± 37.9 | 0.71 |
Consistency antibiogram/antibiotic therapy | |||
Consistentb | 5 | 1 | 0.08 |
Inconsistent | 1 | 4 | |